Governor Phil Murphy signed legislation tightening New Jersey gun laws; the FDA temporarily suspended the ban on Juul sales; researchers found a cancer drug reduced risk of death among people hospitalized with COVID-19 by half.
New Jersey Governor Phil Murphy signed legislation Tuesday that would make it harder for individuals to obtain a handgun license and purchase high-capacity rifles in the state, The New York Times reported. The new legislation requires individuals to receive training to get a gun license and register firearms purchased out of state, and outlaws .50-caliber weapons. This news follows the Supreme Court’s decision to overturn a New York state gun law, and multiple shootings over Independence Day weekend.
The FDA temporarily suspended its ban on Juul sales, the agency announced Tuesday, clarifying this does not entirely rescind the ban. As reported by The Hill, the FDA found scientific issues unique to Juul’s application that require further review. During this time, Juul is also permitted to market its products in the United States. This announcement was made 2 weeks after the FDA ordered Juul to pull its e-cigarettes from the US market.
Experimental drug sabizabulin was initially developed for cancer treatment, but has been found to reduce the risk of death among people hospitalized with COVID-19 by half, The New York Times reported. According to a study published in The New England Journal of Medicine, the drug was more effective at reducing death compared with other drugs, and works by blocking cells from building microtubules. Because the study only included 134 patients, experts have expressed caution in interpreting the results, and encourage more, larger studies.
Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access to and affordability of health care.
Read More
Bridging the Vaccination Gap: Insights on Global Immunization Challenges
July 30th 2024On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Support and Skepticism Emerge as Reactions to Robert F. Kennedy Jr’s HHS Nomination
November 15th 2024In the hours after President-elect Donald J. Trump tapped Robert F. Kennedy Jr to lead HHS, reactions came swiftly to the controversial pick who would have a large influence to shake up public health.
Read More